Post by account_disabled on Dec 28, 2023 10:06:48 GMT
APCO reveals business direction for 2020, growing more than last year. Aiming to maintain gross profit margins not lower than 80% accelerate strategy adjustment Join hands with partners to open CTL ImmunePlus Center and APCO Wellness Center to expand the international customer base. Ready to increase sales channels both domestically and abroad. Prepare to provide the highest returns to shareholders. Prof. Dr. Pichet Wiriyachitra, Chief Executive Officer of Asian Phytoceuticals Public Company Limited or APCO, owner of a natural innovation business for health and beauty with integrated research, development, production and distribution, revealed that Business operations direction in 2020 is expected to return to create more growth from the previous year.
By adjusting the strategy Cooperate B2B Email List with partners Expand customer base both domestically and abroad Including adding distribution channels Aiming to maintain a gross profit margin of not less than 80%. For expanding the international customer base The company is collaborating with Singaporean partners to open the CTL ImmunePlus Center to take care of people with HIV/AIDS until they are in HIV remission or functional cure in Bangkok. It is expected to be operational by February. Also preparing to open the APCO Wellness Center, an immunotherapy center. using APCO products together with modern medical innovations In order to increase efficiency in caring for self-allergies and cancer, it is expected that the service will be open in the second quarter.
Both of these centers mainly focus on serving foreign customers. With coordination from Mr. Lim Ho Kee, who is preparing to take the position of director of the company. The company is also in talks with distributors to bring its HIV/AIDS and cancer products into Nigeria, Ethiopia and other countries that need them. The company will also be testing products for diabetic patients in China. by specialist doctors in the hospital If there is a good response, the diabetes products will be able to be sold in China immediately. While conducting business in the country The company focuses more on marketing through Social Media, both selling through BIM Health Center and distributors.
By adjusting the strategy Cooperate B2B Email List with partners Expand customer base both domestically and abroad Including adding distribution channels Aiming to maintain a gross profit margin of not less than 80%. For expanding the international customer base The company is collaborating with Singaporean partners to open the CTL ImmunePlus Center to take care of people with HIV/AIDS until they are in HIV remission or functional cure in Bangkok. It is expected to be operational by February. Also preparing to open the APCO Wellness Center, an immunotherapy center. using APCO products together with modern medical innovations In order to increase efficiency in caring for self-allergies and cancer, it is expected that the service will be open in the second quarter.
Both of these centers mainly focus on serving foreign customers. With coordination from Mr. Lim Ho Kee, who is preparing to take the position of director of the company. The company is also in talks with distributors to bring its HIV/AIDS and cancer products into Nigeria, Ethiopia and other countries that need them. The company will also be testing products for diabetic patients in China. by specialist doctors in the hospital If there is a good response, the diabetes products will be able to be sold in China immediately. While conducting business in the country The company focuses more on marketing through Social Media, both selling through BIM Health Center and distributors.